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Abstract
Background: Traditional epidemiological studies do not allow elucidating the reality of referral
and diagnosis patterns of dementia in routine clinical practice within a defined territory. This
information is useful and necessary in order to plan and allocate healthcare resources. This paper
presents the results from a dementia case registry based on epidemiological surveillance
fundamentals.
Methods: Standardised registry of dementia diagnoses made in 2007 by specialised care centres
in the Health Region of Girona (RSG) (Spain), which encompasses an area of 5,517 sq. km and a
reference population of 690,207 inhabitants.
Results:  577 cases of dementia were registered, of which 60.7% corresponded to cases of
Alzheimer's disease. Presenile dementia accounted for 9.3% of the cases. Mean time between the
onset of symptoms and clinical diagnosis was 2.4 years and the severity of the dementia was mild
in 60.7% of the cases. High blood pressure, a family history of dementia, dislipidemia, and a past
history of depression were the most common conditions prior to the onset of the disease (>20%).
Conclusion: The ReDeGi is a viable epidemiological surveillance device that provides information
about the clinical and demographic characteristics of patients diagnosed with dementia in a defined
geographical area.
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Background
Epidemiology research in the area of dementia has been
carried out on the basis of cross-sectional observational
studies and longitudinal cohort studies that have estab-
lished the prevalence, incidence and mortality rates of the
main subtypes of dementia. [1] These studies have also
made it possible to identify risk factors and open new
research lines. [2,3] Nevertheless, this methodological
approximation, due to its high economic cost and the
logistic complexity that the follow-up of participants over-
long periods of time represents, provides limited informa-
tion on the impact of the dementia cases on the healthcare
system in terms of needs and utilisation of resources. [4]
Moreover, this type of studies does not allow to elucidate
what the reality of detection, referral and diagnosis is in
routine clinical practice of primary care services and spe-
cialised care in a specific territory. However, given the pro-
gressive ageing of the population, this information is
essential for proper planning and allocation of health and
social care services in the territory, in accordance with
patient needs at mid and long term. Other epidemiologi-
cal strategies such as a clinical registry of cases in a delim-
ited geographical area could be a complimentary
approach.
The creation of registries for certain diseases is standard
procedure in some pathologies such as cancer or cardio-
vascular diseases but uncommon in the area of dementias
certain. A number of initiatives do exist however such as
the Consortium to Establish a Registry for Alzheimer's
Disease (CERAD) [5] and others. [6-8] Nevertheless, these
initiatives, of variable duration, have mainly been geared
towards the creation of cooperative networks, the primary
objective of which, by means of clinical procedures and
standardised diagnoses, is to increase the statistical power
of the clinical research. At present, there are only two
dementia registries for which references can be found in
the specialised literature [9-12], although these registries
have non-comparable methodologies and registry scopes.
The objective of this paper is to present descriptive data
for 2007 from the Registry of Dementia of Girona
(ReDeGi), a clinical registry of dementia cases based on
the guidelines of epidemiological surveillance. [13]
Methods
Design
Consecutive and standardised registry of new dementia
cases in a delimited geographical area.
Geographical area of reference and population under 
surveillance
The Health Region of Girona (RSG) is located in the
north-east of Catalonia (Spain). It has an extension of
5,517 km2, a population of 690,207 inhabitants (accord-
ing to data from the Citizens Municipal Registry 2007)
and a population density of 125.1 inhabitants/km2. The
RSG includes 221 municipalities, 91 of which (43.5%)
have 500 or less inhabitants, representing 4.3% of the
population. Eighty per cent of the municipalities have
3,000 or less inhabitants and only eight municipalities
have over 20,000 registered inhabitants. The RSG is com-
posed of seven healthcare sectors that virtually coincide
with the political-administrative division of the territory
into 7 boroughs (Alt Empordà, Baix Empordà, Garrotxa,
Gironès, Pla de l'Estany, Ripollès and Selva). The RSG pro-
vides 6 borough hospitals (healthcare level I) and a refer-
ence university hospital (healthcare levels I and II), with
each hospital having an allocated reference population.
Figure 1 shows the municipalities that make up the catch-
ment area of each hospital and the number of inhabitants
stratified into large groups. The ReDeGi keeps up a registry
of new cases of dementia diagnosed in the 7 RSG hospi-
tals.
Case registry
The ReDeGi fulfil the Centers for Disease Control (CDC)
guidelines for evaluating a surveillance system [13]: it
controls an assigned population under surveillance and
provides standardised criteria for case definition and a
simple and flexible system for data collection. The meth-
odological principles and the functional structure of the
ReDeGi have been previously described. [14,15] In brief,
the ReDeGi registers all new cases of dementia diagnosed
in hospitals pertaining to the RSG, in accordance with the
clinical diagnosis criteria established for dementia syn-
drome and the different subtypes according to the Diag-
nostic and Statistical Manual of Mental Disorders (DSM-
IV-TR). [16] In a complementary fashion, clinical research
criteria are used. [17-23] Diagnoses may have been made
in the neurology or geriatrics outpatient consultation
offices of each hospital. Case identification and notifica-
tion to the ReDeGi is performed by the actual consultants
of each RSG hospital that conducted the diagnostic proc-
ess of dementia. A technician from the ReDeGi regularly
visits the RSG hospitals and reviews the medical records of
the dementia cases notified, writing the information in a
4-section data collection form: 1- identification of the cen-
tre (name of the hospital, date of admission and medical
record number); 2- sociodemographics (date of birth, sex,
nationality, place of residence, work position, schooling
level, marital status, type of housing and healthcare refer-
ral device); 3- diagnosis characteristics (approximate date
of the onset of symptoms, date of the diagnosis, DSM-IV-
TR diagnostic criteria, additional diagnostic criteria for the
subtype of dementia); 4- clinical data (score and date of
administration of the Mini-Mental State Examination
(MMSE) [24], score and date of administration of the
Blessed Dementia Rating Scale (BDRS) [25], score of the
Clinical Dementia Rating (CDR) [26], a past family his-BMC Neurology 2009, 9:5 http://www.biomedcentral.com/1471-2377/9/5
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tory of dementia, present diagnosis of hypertension, dia-
betes mellitus, dislipidemia, stroke, thyroid disease and a
past history of depressive disorder). The collected infor-
mation is then entered into an electronic database that
meets the confidentiality requirements for personal data
protection in compliance with Spanish legislation.
Diagnosis of dementia
The validity of the diagnosis is based on the premise of
validity of the diagnostic process on the part of the spe-
cialist physicians collaborating with the ReDeGi. Special-
ist physicians from each hospital (specialists in neurology
or geriatrics) performed the registered diagnoses of
dementia. Diagnosis was established on the basis of the
medical history, an interview the patient and a close
observer (family member or carer), a general medical
examination, results from laboratory tests (haematology
and basic biochemistry tests) and diagnostic neuroimag-
ing (computerised axial tomography and/or brain mag-
netic resonance) when needed. The age of onset of
symptoms was determined within the context of the inter-
view with the informant during the diagnosis process.
During this interview the specialist physician ask the
informant about the approximate date of the onset of
symptoms.
Statistical analysis
A descriptive analysis of the variables was carried out
using central tendency and dispersion measures for quan-
titative variables and absolute and relative frequency
measures for qualitative measures. The relative frequen-
cies for the entered diagnoses of dementia were calculated
and stratified by sex and the severity of the dementia.
Bivariate statistical analysis was carried out to determine
the existence of significant differences according to the sex
and the severity of the dementia by applying parametric
Number of inhabitants per municipality in the catchment area of RSG hospitals Figure 1
Number of inhabitants per municipality in the catchment area of RSG hospitals.BMC Neurology 2009, 9:5 http://www.biomedcentral.com/1471-2377/9/5
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and non-parametric techniques, according to the distribu-
tion of data. [27]
To estimate the diagnostic coverage in the registry's catch-
ment area, a dementia prevalence of 5.4% and an inci-
dence of 8.8 cases were assumed per 1,000 people per year
at risk for individuals aged 60 and over. These values were
estimated by a group of international experts using a Del-
phi consensus. [28] Based on the available evidence from
multiples epidemiological studies carried out all over the
world, this report provides a consensus about the fre-
quency indicators of dementia around the world. Specifi-
cally, the rates used in this study correspond to the
geographic area known as EURO A, which includes West-
ern European countries. Data for the population in the
catchment are of the registry correspond to those pub-
lished by the National Institute of Statistics for the referred
area. [29] Results are expressed as absolute numbers and
percentages, median (range) and mean (standard devia-
tion) values, and 95% confidence intervals (CI). A statis-
tical significance level of 95% was set for hypothesis
contrasts.
Results
Viability of the data collected
Most of the information required by the ReDeGi was doc-
umented in the medical chart of the patients, which also
showed a low frequency of lost values in the 28 variables.
The variable that presented the highest number of missing
values was the approximate date of onset of the symptoms
which was missing in 12.3% (n = 71) of cases, followed by
the schooling level accounting for 11.1% (n = 64), the
presence of a past family history of dementia with 9.5% (n
= 55), healthcare referral device accounting for 7.3% (n =
42), type of housing arrangement 6.1% (n = 35), CDR
score 3.6% (n = 21), MMSE score 2.8% (n = 16) and date
of administration of the MMSE accounting for 2.1% (n =
12).
Subtypes of dementia
Over the course of 2007, 577 cases of dementia were
entered, of which 60.0% were cases of Alzheimer's disease
(AD), 10.7% were cases of mixed dementia (AD + vascular
component), 4.7% were cases of vascular dementia
(VaD), 26.6% corresponded to other subtypes of demen-
tia, and 8.7% to unspecified dementia. The frequency of
presenile dementia with an onset of symptoms before the
age of 66 was 9.3%; mean age in these cases was 58.9 years
(SD = 7.1; Range = 32–64). Table 1 presents the absolute
and relative frequencies of the dementia diagnoses
entered following the DSM-IV-TR diagnostic criteria. Pri-
mary care centres referred 75.2% of the cases, 10.1% were
referred by a hospital medical department, 2.8% by the
Mental Health Network and the remaining 4.7% by long-
term care centres and other private means of healthcare.
Demographic and clinical characteristics
Mean age was 78.9 years (SD = 7.8; Range = 33–95) and
62.6% were women. Mean age for males was lower than
that of females (76.9 years vs. 80.3 years; p < 0.001).
60.7% of the cases were mild dementia, 26.5% were mod-
erate and 9.2% severe. As regards the education, 21.3%
Table 1: Absolute and relative frequency of dementia diagnoses included in the registry according to DSM-IV-TR criteria
n (%)
Alzheimer's type dementia [F00]
- early non-complicated onset [F00.00] 7 (1.2)
- early onset with a depressed mood [F00.03] 2 (0.3)
- late non-complicated onset [F00.10] 255 (44.2)
- late onset with delusional ideation [F00.11] 38 (6.7)
- late onset with a depressed mood [F00.13] 44 (7.7)
Vascular dementia [F01]
- non-complicated [F01.80] 18 (3.1)
- with delusional ideation [F01.81] 2 (0.3)
- with a depressed mood [F01.83] 7 (1.2)
Dementia caused by Pick's disease [F02.0] 23 (4.0)
Dementia associated with Parkinson's disease [F02.3] 15 (2.7)
Alcohol-induced persistent dementia [F10.73] 1 (0.1)
Dementia caused by non-specified diseases [F02.8]
- non-specified 14 (2.5)
- Lewy's bodies 32 (5.6)
- head injury  1 (0.1)
- corticobasal degeneration 1 (0.1)
- supranuclear progressive palsy 4 (0.7)
- multiple aetiologies (Alzheimer's + vascular component) 62 (10.7)
Dementia caused by Creutzfeldt-Jakob's diseases [F02.1] 1 (0.1)
Non-specified dementia [F03] 50 (8.7)BMC Neurology 2009, 9:5 http://www.biomedcentral.com/1471-2377/9/5
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were illiterate or had never attended school, 60.1% had
between 1 and 8 years of schooling and only 7.4% had 9
or more years of schooling. 45.2% of the patients were
married or had a live-in partner, 42.3% were widowers or
widows. There were also significant differences regarding
the marital status (13.9% of widowed men as compared
to 59.3% of widowed women; p < 0.001). The place of res-
idence was their own home in 59.4% of the cases, the res-
idence of a family member in 28.2% of the cases and only
6.6% of the cases lived in a nursing home. The percentage
of patients who lived in their own home was greater in
men (82.7% vs. 52.2%) whom also showed a lower per-
centage of nursing home residence than women (3.6% vs.
8.4%; p < 0.001).
Mean time of progression from the onset of the first symp-
toms to the time of diagnosis was 2.4 years (SD = 1.8;
Range = 0.1–10.3), with no differences regarding patient
gender (p = 0.059). Mean MMSE and BDRS scores were
16.8 (SD = 5.4; Range = 0–29) and 7.9 (SD = 4.3; Range =
0.5–22) respectively. A lower MMSE score was observed in
women (16.2 vs. 18.1; p < 0.001) and a greater score in
the BDRS cognitive subscale (3.8 vs. 3.2; p < 0.001) as well
as in the BDRS functional scale (1.4 vs. 0.9; p = 0.016), but
not so in the behavioural disturbances subscale (3.0 vs.
3.3; p = 0.086).
In 25.1% (n = 145) there was a past family history of first-
level dementia (29.2% in males and 26.9% in women; p
= 0.567), 50.6% of cases had been diagnosed with high
blood pressure (42.1% in males and 56.5% in females; p
= 0.001), 17.3% had been diagnosed with DM (n = 100)
(19.9% in males and 16.1% in females; p = 0.240), in
25.1% there was a diagnosis of dislipedimia (21.3% in
males and 27.8% in females; p = 0.083), in 14.0% (n =
81) there was a past history of CVA or stroke (19.0% in
males and 11.2% in females; p = 0.010), in 5% a diagnosis
of thyroid disease (2.3% in males and 5.9% in females; p
= 0.045), in 21.3% (n = 123) a past history of depression
(16.7% in males and 24.5% in females; p = 0.027). Table
2 shows the main clinical and demographic characteristics
stratified according to the severity of the dementia in
accordance with the CDR score.
Table 2: Clinical and sociodemographic characteristics stratified according to CDR*
CDR 1 CDR 2 CDR 3
Age, mean (SD) 77.5 (7.6) 81.4 (6.5) 83.0 (7.1)
Females, n (%) 207 (59.3) 102 (66.7) 40 (75.5)
Schooling, n (%)
Illiterate/not attending school 68 (21.3) 38 (27.7) 16 (34.8)
Between 1 and 8 years 220 (69.2) 91 (66.4) 27 (58.7)
9 and over 30 (9.5) 8 (5.9) 3 (6.5)
Marital status, n (%)
Single/separated 12 (3.7) 9 (6.2) 6 (12.3)
Married/partner 183 (56.7) 55 (38.2) 13 (26.5)
Widower 128 (39.6) 80 (55.6) 30 (61.2)
Residence, n (%)
Own home 241 (74.6) 74 (49.3) 17 (32.7)
Home of family member/other 75 (23.2) 61 (40.7) 25 (48.1)
Nursing Home 7 (2.2) 15 (10.0) 10 (19.2)
Referral device, n (%)
Primary Care 268 (76.8) 119 (77.8) 37 (69.8)
Others 81 (23.2) 34 (22.2) 16 (30.2)
Years of evolution, mean (SD) 1.9 (1.5) 2.6 (1.7) 3.1 (2.4)
MMSE, mean (SD) 19.1 (4.5) 14.0 (4.5) 10.5 (5.3)
BDRS, mean (SD)
Cognitive function 2.8 (1.2) 4.6 (1.4) 5.7 (1.5)
Functional capacity 0.2 (1.5) 2.0 (1.5) 4.9 (2.3)
Behaviour 2.7 (1.7) 3.7 (2.0) 3.0 (1.8)
Past family history of dementia, n (%) 102 (31.5) 27 (19.9) 13 (27.7)
Diagnosis of high blood pressure, n (%) 166 (47.7) 86 (56.6) 32 (62.7)
Diagnosis of diabetes mellitus, n (%) 57 (16.4) 27 (17.9) 11 (21.6)
Diagnosis of dislipidemia, n (%) 91 (26.1) 32 (21.1) 16 (31.4)
Diagnosis of stroke, n (%) 38 (10.9) 30 (19.9) 7 (13.7)
Diagnosis of thyroid disease, n (%) 16 (4.6) 8 (5.3) 1 (2.0)
Past history of depression, n (%) 86 (24.7) 27 (17.9) 5 (9.8)
* Results for available data; CDR: Clinical Dementia Rating; MMSE: Mini-Mental State Examination; BDRS: Blessed Dementia Rating ScaleBMC Neurology 2009, 9:5 http://www.biomedcentral.com/1471-2377/9/5
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Diagnostic coverage in the catchment area
In accordance with the 2007 Municipal Census Registry,
the RSG population embraced 690,207 inhabitants, of
which, 15.8% were over the age of 65. In accordance with
these data and based on the estimated prevalence (5.4%),
the number of prevailing cases of dementia in the territory
amounted to 6.034, with 103.433 people over the age of
65 being at risk of developing dementia in 2007. In
accordance with the incidence rate used, (8.8/1,000), the
estimated number of new dementia cases for the territory
in 2007 was 910 cases. Taking into account that out of the
577 entered cases of dementia 570 corresponded to RSG
inhabitants, the registry's coverage embraced 61.3% (CI
95% = 59.4–65.8) of the cases. Table 3 shows data per-
taining to the registry's coverage for the catchment area of
each hospital within the RSG region. The raw incidence of
new dementia diagnosis in the RSG during 2007 was 5.5/
1.000.
Discussion
Dementia is a disease that fulfils the parameters proposed
by the CDC in order to assess the importance and need for
an epidemiological surveillance system in terms of public
health: frequency and severity, differences and dissimilar-
ities amongst population groups, high cost, potential of
primary and secondary prevention, and public interest.
[13] The ReDeGi sets out from a conceptual model of reg-
istry, which fulfil the CDC guidelines for evaluating a sur-
veillance system and is adapted to the particular needs of
dementia. [14] Following a 2-year long test in which the
operating structure of a registry system took the lead with
satisfactory results [15], 2007 represented the start of
activity of the ReDeGi in the entire RSG area which
extends for 5,517 km2  and includes a population of
690,207 inhabitants. The results obtained are an innova-
tion with regard to the existing dementia registries and can
be evaluated from a point of view of methodology or from
a practical utility perspective.
On the one hand, from a strictly methodology perspec-
tive, the ReDeGi has adopted a registry model different to
those used by the South Carolina Alzheimer's Registry and
by the New York State Dementias Registry. The first of
these is based on the integration of computerised data
originating from different sources of information. The
information entered includes the diagnosis of dementia
(ICD-9 criteria), other medical diagnoses and basic demo-
graphic data. The information that enables the elabora-
tion of a registry is circumscribed to the stratification of
dementia subtypes according to demographic and admin-
istrative characteristics such as gender, race or age, and to
the origin of the particular case. Access to death certificates
via a link also allows estimating the mortality rates of
entered cases from a certain inclusion date in the registry
onwards. [11,12,30] Even though the New York State
Dementias Registry only admits cases of dementia (ICD-9
criteria) from discharge forms from all the hospitals in the
state of New York, it does allow to carry out an estimate of
the hospitalisations required by patients with dementia
and their causes as well as the type of admission and des-
tination at discharge. [9,10] Unlike the previously men-
tioned registries, which are based on information from
electronic databases, the ReDeGi is characterised by the
compilation of data straight from the patient's medical
chart by a ReDeGi technician. This method allows the
standardised registration of clinical information available
in the patient's medical history. Moreover, it is a proce-
dure that permits the maintenance of a dementia subtypes
registry in accordance with DSM-IV criteria and other
diagnostic criteria specific to the subtypes of dementia
that ICD-9 and administrative databases are unable to reg-
ister. For example, in table 1 cases with the diagnostic cat-
egory "Dementia caused by non-specified diseases"
include a subcategory named "Lewy's bodies" that corre-
spond to those cases that accomplished the diagnostic cri-
teria for dementia with Lewy bodies, and the 23 cases
under "dementia caused by Pick's disease" diagnostic cat-
egory correspond to 18 cases that accomplished the diag-
nostic criteria for frontotemporal dementia and 5 cases
Table 3: Catchment population and diagnostic coverage according to the health sector within the RSG
Geographical 
catchment area
Catchment area >64 years (%) Estimated number of 
prevalent cases
Estimated number of 
incident cases
Registered cases (%)
H. Girona 141,924 20,585 (14.5) 1,132 171 120 (70.2)
H. Salt 133,983 20,182 (15.1) 1,110 168 131 (78.0)
H. Olot 53,187 10,942 (20.6) 602 91 40 (44.0)
H. Figueres 131,556 21,730 (16,5) 1,195 181 69 (38.1)
H. Blanes 79,027 9,794 (12,4) 539 81 80 (98.8)
H. Palamós 124,192 20,059 (16,2) 1,103 167 72 (43.1)
H. Campdevànol 26,338 6,175 (23.4) 340 51 58 (100.0)
Total* 690,207 109,467 (15.9) 6,034 910 570 (61.3)
* 7 cases entered corresponded to patients domiciled outside the RSG areaBMC Neurology 2009, 9:5 http://www.biomedcentral.com/1471-2377/9/5
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the diagnostic criteria for primary progressive aphasia. In
this sense, the data collection procedure implemented at
the ReDeGI ensures greater validity of the information
recorded in the registry related to the diagnosis.
On the other hand, from a strictly pragmatic point of
view, the data obtained from the ReDeGi provide relevant
information about the healthcare pressure brought about
emerging dementia cases in a certain territory over a
defined period of time. The ReDeGi provides evidence on
the distribution of the dementia subtypes and the clinical
and demographic characteristics of patients who contact
specialist healthcare devices.
The analysis of the data shows that AD accounted for
60.1% of the entered cases, mixed dementia (AD + vascu-
lar component) for 10.7% and vascular dementia (VaD)
for 4.6%. These percentages are similar to those from the
South Carolina Alzheimer's Disease Registry, in which the
AD cases entered in the period 1988–2003 accounted for
64% of the total and VaD cases accounted for the remain-
ing 14%. In relation to the place of residence of the
patients, the differences between the South Carolina
Alzheimer's Disease Registry and the ReDeGi can reflect
two distinct sociocultural and healthcare models. In the
former model, 57% of the cases live in the community
and 38% in assisted centres, whereas in the latter 83.1%
live in the community (their own home or the home of a
family member) and 6.6% live in long-term care centres.
Data on the mean time between the onset of symptoms
and clinical diagnosis indicate that for most dementias
the mean time from onset to diagnosis is approximately 2
years. In this sense, it is hard to establish a precise date of
dementia onset, although the estimate based on the data
collected by the informant carer has proven to be a relia-
ble source of information. [31]
The diagnostic coverage of the registry has been estimated
to be 61.3% of the total expected cases in the territory,
with differences being observed amongst the different
healthcare sectors. However, there are certain limitations
that should be taken into account when estimating the
diagnostic coverage on the basis of expected number of
dementia cases per year in the catchment area. Formally,
in an epidemiological study, the incidence rate would be
calculated dividing the number of cases detected in speci-
fied period by the free-of-disease inhabitants by time unit.
However, the cases entered in the registry correspond to
patients who were referred to a specialised diagnostic unit,
some of whom presented moderate to severe severity and
a mean time of 2 years from onset of symptoms to time of
diagnosis. These are new cases of dementia for healthcare
devices and consequently the results of the estimated
diagnostic coverage are not representative of the real inci-
dence in the general population. These results can how-
ever be reliably used to ascertain the incidence of new
cases that contact specialised health services. A possible
explanation for the number of cases not registered
(38.7%) could be hypothetized that they correspond to
mild or advanced cases of dementia. It may be that the
first group did not attend specialised consultations due to
the low impact of the symptoms of dementia in the early
stages and the second group did not attend consultations
because the benefit of a diagnostic could be more limited.
It is interesting to note that we have observed a great vari-
ation in the diagnostic coverage across hospitals. These
differences might due to different variables and may help
to identify factors related to the referral and diagnosis in
clinical practice. For example, these differences may be
due to differences between types of specialist physicians
(neurology or geriatrics) or due to the existence of specific
devices for dementia diagnostic. However, it is important
to emphasise that, for the ReDeGi, more than achieve a
full diagnostic coverage, it is more important to register all
cases that have been diagnosed in the 7 RSG hospitals.
Thus, the ReDeGi will become a powerful information
device in few years when it provides cumulative informa-
tion about the pressure of dementia cases and its evolu-
tionary course.
Conclusion
The ReDeGi illustrates the application of epidemiologic
surveillance to the setting of a chronic condition such as
dementia and for which the available information usually
comes from such dispersed sources as vital statistics,
health surveys, hospital discharges, etc.
The ReDeGi is a valid, representative and updated source
of information of great utility for the planning and alloca-
tion of the health and social care services needed by
patients with dementia and of great special interest to
healthcare administrators. The main limitation is that
actually, the ReDeGi can't provide dementia incidence
rates for its geographical area. However, as the ReDeGi
continues registering new dementia diagnosis, in few
years it will be possible to identify all cases with a reported
onset during each calendar year, and to obtain population
rates by age for variables of interest, such as rates of illiter-
acy or other. Future plans of the ReDeGi encompass an
extension of the influence area of primary care devices at
short term and an annual follow-up of the cases included
in the registry. The proposed annual follow-up of regis-
tered cases will allow us to gain further insight into the
course of the disease and to ascertain the percentage of
cases that continue to live at their homes, the number of
cases that are admitted into long-term care centres and the
number of cases that die, as well as the clinical and demo-
graphic variables associated with such changes. The main-
tenance and extension of the registry over the next few
years will allow us to describe how the pressure on health-BMC Neurology 2009, 9:5 http://www.biomedcentral.com/1471-2377/9/5
Page 8 of 9
(page number not for citation purposes)
care services evolves and to determine the clinical features
and course of the cases diagnosed with the disease.
Although actually mild cognitive impairment (MCI) is a
controversial diagnostic category [32], a potential applica-
tion of the ReDeGi in the future may be to register cases
with this diagnostic category from the neurology or geriat-
rics outpatient consultation offices using the same meth-
odology. However, due to the low validity and reliability
of the actual diagnostic criteria for MCI, this possibility
will be considered in the future. An other potential appli-
cation of the ReDeGi may be to conduct etiologic case-
control studies by selecting comparable control subjects
from primary care databases, to determine, for example,
the odds of dementia between diabetic and non-diabetic
patients. Moreover, this application will contribute to a
better interpretation of the clinical characteristics of
dementia patients respect the general population.
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